Gastroenteritis Escherichia Coli
5 clinical trials · Condition
◉ Watch Gastroenteritis Escherichia Coli
| Record | Firm | Date |
|---|---|---|
| A Double-Blind Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic Area (NCT03548064) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-03-10 |
| Phase 1 Study of dmLT ID Vaccination in Healthy Adults (NCT02531685) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-06-02 |
| Safety of Sublingual dmLT for ETEC (NCT02052934) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-03-10 |
| Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult Subjects (NCT00654108) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-06-02 |
Track Gastroenteritis Escherichia Coli automatically
Every clearance here is in the API, with alerts when new ones post.